| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/04/2003 | CA2271478C Tissue specific expression of retinoblastoma protein |
| 02/04/2003 | CA2095633C Enrichment method for variant proteins with altered binding properties |
| 02/04/2003 | CA2063810C Production of vascular endothelial cell growth factor |
| 02/03/2003 | WO2002016548A2 Novel g protein-coupled receptor |
| 02/03/2003 | CA2418130A1 Novel g protein-coupled receptor |
| 01/30/2003 | WO2003008571A2 Chimeric chains that code for proteins that induce effects directed against viruses |
| 01/30/2003 | WO2003008548A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 01/30/2003 | WO2003008455A1 Activity monitor molecules for g-protein trimer |
| 01/30/2003 | WO2003008454A2 Glycoprotein vi fusion proteins |
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003007978A1 Alpha-fetoprotein peptides and uses thereof |
| 01/30/2003 | WO2003007971A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | WO2003007889A2 Therapeutic agents comprising pro-apoptotic proteins |
| 01/30/2003 | WO2002068585A9 Tip39 polypeptides |
| 01/30/2003 | WO2002026988A3 Human drug metabolizing enzymes |
| 01/30/2003 | WO2001090359A3 G-protein coupled receptors |
| 01/30/2003 | WO2001079286A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 01/30/2003 | WO2001064877A9 Human schizophrenia gene |
| 01/30/2003 | US20030023993 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation |
| 01/30/2003 | US20030023038 For therapy of undesired cell proliferation; for stimulation and inhibition of lymphocytes |
| 01/30/2003 | US20030022819 Administering to an animal an angiogenic amount of a hedgehog polypeptide or agonist to promote angiogenesis |
| 01/30/2003 | US20030022308 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 01/30/2003 | US20030022284 Polypeptide for use in the diagnosis and treatment of kidney defects |
| 01/30/2003 | US20030022238 Methods of identifying agents which inhibit GPR-9-6 |
| 01/30/2003 | US20030021794 Heat shock protein-based vaccines and immunotherapies |
| 01/30/2003 | US20030021765 Polymer conjugates of interferon beta-1a and uses |
| 01/30/2003 | CA2454226A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | CA2453986A1 Glycoprotein vi fusion proteins |
| 01/30/2003 | CA2453967A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453965A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/29/2003 | EP1278871A2 Human phospholipase c delta 5 |
| 01/29/2003 | EP1278870A1 Splice variant of camp phosphodiesterase type 7 (pde7a3) |
| 01/29/2003 | EP1278866A2 Serine-threonine kinase |
| 01/29/2003 | EP1278863A2 Human serine-threonine kinase-4 |
| 01/29/2003 | EP1278854A2 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/29/2003 | EP1278851A1 Humanised antibodies to the epidermal growth factor receptor |
| 01/29/2003 | EP1278848A1 New ras guanine-nucleotide-exchange factor 1 (nrg1) |
| 01/29/2003 | EP1278847A1 New gtpase-activating protein 1 |
| 01/29/2003 | EP1278843A2 Rna metabolism proteins |
| 01/29/2003 | EP1278778A2 Modified peptides, comprising an fc domain, as therapeutic agents |
| 01/29/2003 | EP1278777A2 G protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/29/2003 | EP1278770A1 Human wingless-like gene |
| 01/29/2003 | EP1278767A1 Albumin fusion proteins |
| 01/29/2003 | EP1278765A2 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use |
| 01/29/2003 | EP1278544A2 Albumin fusion proteins |
| 01/29/2003 | EP1278534A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/29/2003 | EP1002110B1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 01/28/2003 | US6512103 Mammalian chemokine reagents |
| 01/28/2003 | US6511829 Combine the inherent strong visible fluorescent properties of GFPs with the anionic phospholipid binding specificity of annexins; selectively labeling apoptotic cells |
| 01/23/2003 | WO2003006623A2 Directed protein modificaiton by iterative sequence insertion |
| 01/23/2003 | WO2003006609A2 Human cytokine receptor |
| 01/23/2003 | WO2003006499A2 Survivin interacting protein tpr1 |
| 01/23/2003 | WO2003006493A2 Histidine phosphatase interacting protein with 180kd |
| 01/23/2003 | WO2003005819A1 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent |
| 01/23/2003 | WO2002086058A3 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 01/23/2003 | WO2002053711A3 Use of transcription factor yb-1 in adenoviral systems |
| 01/23/2003 | WO2002033095A3 Regulation of human serine-threonine protein kinase |
| 01/23/2003 | WO2002029059A3 Nogo receptor homologs |
| 01/23/2003 | WO2002020619A3 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 01/23/2003 | WO2002010405A3 A human disintegrin protein |
| 01/23/2003 | WO2001090358A3 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | WO2001072768A3 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same |
| 01/23/2003 | US20030018181 Antiinflammatory agents; culturing; isolation of fusion protein |
| 01/23/2003 | US20030018007 Compositions and methods for inducing gene expression |
| 01/23/2003 | US20030017991 Substrates and assays for beta-secretase activity |
| 01/23/2003 | US20030017617 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | US20030017538 Genetically engineered protein for use as diagnostic tool in gentic analysis |
| 01/23/2003 | US20030017478 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2003 | US20030017163 Compounds for targeting |
| 01/23/2003 | US20030017161 Polypeptides that are capable of modulating apoptosis; also Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 |
| 01/23/2003 | US20030017140 Retroviral vector particles have a chimeric envelope protein consisting of an antigen binding site of an antibody or another peptide, fused to the envelope protein the retroviral vector. |
| 01/23/2003 | US20030017134 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/23/2003 | CA2453496A1 Survivin interacting protein tpr1 |
| 01/23/2003 | CA2453494A1 Histidine phosphatase interacting protein with 180kd |
| 01/23/2003 | CA2453285A1 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent |
| 01/23/2003 | CA2449411A1 Human cytokine receptor |
| 01/22/2003 | EP1276882A2 Method for genetically modifying a plant |
| 01/22/2003 | EP1276868A2 Identification of human gaba transporter |
| 01/22/2003 | EP1276856A1 Albumin fusion proteins |
| 01/22/2003 | EP1276849A2 Albumin fusion proteins |
| 01/22/2003 | EP1276770A1 Proteins with a high immunoreactivity and a method for the production thereof |
| 01/22/2003 | EP1276762A1 Porphyromonas gingivalis recombinant proteins and truncations |
| 01/22/2003 | EP1276761A2 New bromodomain protein |
| 01/22/2003 | EP0832199A4 Fucosyltransferase genes and uses thereof |
| 01/22/2003 | EP0610436B1 Hepatitis-c virus testing |
| 01/22/2003 | EP0540651B1 Endogenously sweetened transgenic plant products |
| 01/21/2003 | US6509453 Use of oil bodies and their associated proteins as affinity matrices for the separation and purification of target molecules from samples |
| 01/21/2003 | US6509450 Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509016 Delaying recurrence of ganglioside 2 associated tumors; antibody comprising the light and heavy chain variable region sequences contained in seq id no: 2 and 4 |
| 01/21/2003 | CA1341416C Hirudine variants, their use and preparation process |
| 01/16/2003 | WO2003005636A1 Secure header information for multi-content e-mail |
| 01/16/2003 | WO2003004651A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | WO2003004650A2 Group b streptococcus antigens and corresponding dna fragments |
| 01/16/2003 | WO2003004648A1 Anti_human ovarian cancer -anti_cd3 bispecific antibody |
| 01/16/2003 | WO2003004604A2 Phage displayed pdz domain ligands |
| 01/16/2003 | WO2003004066A1 Gene therapeutics |
| 01/16/2003 | WO2003004047A1 Cell death inducers for mast cells |
| 01/16/2003 | WO2002088178A3 Antigens of group b streptococcus and corresponding dna fragments |